EUR USD GBP
+353-1-416-8900REST OF WORLD
1-800-526-8630U.S. (TOLL FREE)

Eli Lilly and Company - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

1 of 3
Summary
Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage.

This report includes Eli Lilly and Company's contact information and business summary, tables, graphs, a list of partners and targets, a breakdown of financial and legal advisors, deal types, top deals by deal value, detailed deal reports, and descriptions and contact details of the partner, target, investor, and vendor firms, where disclosed.

The profile also includes detailed deal reports for all M&A, private equity, public offering, venture financing, partnership and divestment transactions undertaken by Eli Lilly and Company. These deal reports contain information about target company financials, sources of financing, method of payment, deal values, and advisors for various parties, where disclosed.

Key Findings
Eli Lilly and Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital raisings, venture capital investments, ownership and partnership transactions undertaken by Eli Lilly and Company since January 2007.

Synopsis
- Provides intelligence on Eli Lilly and Company's M&A, strategic partnerships and alliances, capital raising and private equity transactions.

- Detailed reports of various financial transactions undertaken by Eli Lilly and Company and its subsidiaries since 2007.

- Information about key financial and legal advisors for Eli Lilly and Company's financial deals transactions.

- Financial deals tables and charts covering deal value and volumes trend, deal types and geography-based deal activity.

Reasons To Buy
- Access comprehensive financial deals data along with charts and graph covering M&A, private equity, and partnerships and alliances.

- Form an independent opinion about Eli Lilly and Company’s growth strategies through the organic and inorganic activities undertaken since 2007.

- Track your competitors’ business structure and growth strategies.

Key Highlights
This report includes Eli Lilly and Company's contact information and business summary, tables, graphs, a list of partners and targets, a breakdown of financial and legal advisors, deal types, top deals by deal value, detailed deal reports, and descriptions and contact details of the partner, target, investor, and vendor firms, where disclosed.

The profile also includes detailed deal reports for all M&A, private equity, public offering, venture financing, partnership and divestment transactions undertaken by Eli Lilly and Company. These deal reports contain information about target company financials, sources of financing, method of payment, deal values, and advisors for various parties, where disclosed.
READ MORE
Note: Product cover images may vary from those shown
2 of 3
COMPANY OVERVIEW AND KEY FACTS
MERGERS & ACQUISITIONS
Mergers and Acquisitions – Overview
Mergers and Acquisitions – Deal reports
CORPORATE VENTURING
Corporate Venturing – Overview
Corporate Venturing – Deal reports
PARTNERSHIP
Partnership – Overview
Partnership – Deal reports
Capital Raising – Deal reports
DIVESTMENTS
Divestments – Overview
Divestments – Deal reports

APPENDIX
About the Author Financial Deals Database
Deal Definition and Methodology
About the Author

List of Tables

Eli Lilly and Company activity by deal type – volume (trailing twelve months (TTM))
Eli Lilly and Company M&A activity by geography (2012 -YTD2016)
Eli Lilly and Company activity by deal type – volume (2012 -YTD2016)
Eli Lilly and Company M&A average deal size – value ($m) (2012 -YTD2016)
Eli Lilly and Company legal advisor ranking by value ($m)
Eli Lilly and Company financial advisor ranking by value ($m)
Top Deals(2012 -YTD2016)
Eli Lilly and Company targets and partners (2012 -YTD2016)
Eli Lilly and Company M&A volume and value trend (2012-YTD2016)
Eli Lilly and Company M&A activity by geography (2012-YTD2016)
Eli Lilly and Company corporate venturing volume and value trend (2012-YTD2016)
Eli Lilly and Company corporate venturing by geography (2012-YTD2016)
Eli Lilly and Company partnership volume and value trend (2012-YTD2016)
Eli Lilly and Company partnership trend by key deal type (2012-YTD2016)
Eli Lilly and Company divestments volume and value trend (2012-YTD2016)
Eli Lilly and Company divestments activity by geography (2012-YTD2016)

List of Figures

Eli Lilly and Company activity by deal type - volume (trailing twelve months (TTM))
Eli Lilly and Company M&A activity by geography (2012-YTD2016)
Eli Lilly and Company activity by deal type - volume (2012-YTD2016)
Eli Lilly and Company M&A average deal size - value ($m)
Eli Lilly and Company M&A volume and value trend (2012-YTD2016)
Eli Lilly and Company M&A activity by geography (2012-YTD2016)
Eli Lilly and Company corporate venturing volume and value trend (2012-YTD2016)
Eli Lilly and Company corporate venturing by geography (2012-YTD2016)
Eli Lilly and Company partnership volume and value trend (2012-YTD2016)
Eli Lilly and Company partnership trend by key deal type (2012-YTD2016)
Eli Lilly and Company divestments volume and value trend (2012-YTD2016)
Eli Lilly and Company divestments by geography (2012-YTD2016)
Note: Product cover images may vary from those shown
3 of 3
Note: Product cover images may vary from those shown
Adroll
adroll